| HTA in der Praxis | Veröffentlichungen Des Instituts Für Deutsches, Europäisches Und Internationales Medizinrecht, Gesundheitsrecht Und Bioethik Der Universitäten Heidelberg Und Mannheim | 2015 |
| Health Economics of TARGIT | | 2014 |
| Comparative Study of Legal Reasoning in Swiss and UK Courts | | 2014 |
| A Review of Economic Evaluations on New Drugs Priced by Cost Calculation Method in Japan | Japanese Journal of Pharmacoepidemiology/Yakuzai Ekigaku | 2012 |
| Preventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and Canada | PLoS ONE | 2016 |
| Mapping PedsQL scores onto CHU9D utility scores: estimation, validation and a comparison of alternative instrument versions | Quality of Life Research | 2020 |
| Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers | Applied Health Economics and Health Policy | 2019 |
| Critical review and quality-assessment of cost analyses in radiotherapy: How reliable are the data? | Radiotherapy and Oncology | 2019 |
| Cost-effectiveness analysis of new generation coronary CT scanners for difficult-to-image patients | European Journal of Health Economics | 2017 |
| Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia | Cost Effectiveness and Resource Allocation | 2017 |
| Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort | European Journal of Health Economics | 2017 |
| Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community | Pharmacoeconomics | 2016 |
| Comparing Drug and Nondrug Technologies in Comparative Effectiveness Research | | 2016 |
| Endoscopic polypectomy in the clinic: a pilot cost-effectiveness analysis | Clinical Otolaryngology | 2016 |
| Pertuzumab in combination with trastuzumab and docetaxel for the treatment of HER2-positive metastatic or locally recurrent unresectable breast cancer | Pharmacoeconomics | 2015 |
| Design of Economic Evaluations of Mindfulness-Based Interventions: Ten Methodological Questions of Which to Be Mindful | Mindfulness | 2015 |
| Output correlations in probabilistic models with multiple alternatives | European Journal of Health Economics | 2015 |
| Comparing Drug and Non-drug Technologies in Comparative Effectiveness Research | | 2015 |
| Introduction to the Technical Issues of Economic Evaluation | | 2015 |
| Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis | Journal of Thrombosis and Thrombolysis | 2015 |
| Cost-effectiveness of the endoscopic versus microscopic approach for pituitary adenoma resection | Laryngoscope | 2015 |
| Cost-Effectiveness and Cost-Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study | Neuromodulation | 2015 |
| Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo | Gastric Cancer | 2015 |
| Making a case for high-volume robotic surgery centers: A cost-effectiveness analysis of transoral robotic surgery | Journal of Surgical Oncology | 2015 |
| Prediction of patient-reported outcome measures via multivariate ordered probit models | Journal of the Royal Statistical Society Series A: Statistics in Society | 2015 |
| Is utility-based quality of life associated with overweight in children? Evidence from the UK WAVES randomised controlled study | BMC Pediatrics | 2015 |
| Review of utility values for economic modeling in type 2 diabetes | Value in Health | 2014 |
| Methods for documenting systematic review searches: a discussion of common issues | Research Synthesis Methods | 2014 |
| Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model | Value in Health | 2014 |
| Sharing risk between payer and provider by leasing health technologies: an affordable and effective reimbursement strategy for innovative technologies? | Value in Health | 2014 |
| Review of mixed treatment comparisons in published systematic reviews shows marked increase since 2009 | Journal of Clinical Epidemiology | 2014 |
| Is the UK NICE "reference case" influencing the practice of pediatric quality-adjusted life-year measurement within economic evaluations? | Value in Health | 2014 |
| The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients | BMC Ophthalmology | 2014 |
| Health-related productivity loss: NICE to recognize soon, good to discuss now | Pharmacoeconomics | 2014 |
| Diminishing marginal disutility of hypoglycaemic events: results from a time trade-off survey in five countries | Quality of Life Research | 2014 |
| Effectiveness and cost-effectiveness of an awareness campaign for colorectal cancer: a mathematical modeling study | Cancer Causes and Control | 2014 |
| Cost-effectiveness of optimizing acute stroke care services for thrombolysis | Stroke | 2014 |
| Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists | Applied Health Economics and Health Policy | 2014 |
| Cost and effectiveness of treatment options for childhood obesity | Pediatric Obesity | 2014 |
| Major molecular response during the first year of dasatinib, imatinib or nilotinib treatment for newly diagnosed chronic myeloid leukemia: a network meta-analysis | Cancer Treatment Reviews | 2014 |
| The effect of hypoglycemia on health-related quality of life: Canadian results from a multinational time trade-off survey | Canadian Journal of Diabetes | 2014 |
| Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin - from the UK health care cost perspective | Diabetes, Obesity and Metabolism | 2014 |
| Effectiveness and cost-effectiveness of a telehealth intervention to support the management of long-term conditions: study protocol for two linked randomized controlled trials | Trials | 2014 |
| Targeted rehabilitation to improve outcome after total knee replacement (TRIO): study protocol for a randomised controlled trial | Trials | 2014 |
| Apixaban, dabigatran, and rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis | Clinical Drug Investigation | 2014 |
| Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: an economic evaluation alongside a randomised controlled trial | Pharmacoeconomics | 2014 |
| Swedish experience-based value sets for EQ-5D health states | Quality of Life Research | 2014 |
| Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure | Journal of Heart and Lung Transplantation | 2014 |
| Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death | Health and Quality of Life Outcomes | 2014 |
| Evaluation of pharmacist care for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis | International Journal of Clinical Pharmacy | 2014 |
